Objective: To verify the feasibility, tolerability and efficacy of the combination of captopril (75 mg/day) and candesartan (8 mg/day) in early postinfarction phases of not thrombolysed and ...
Andersson and Neldam [5] evaluated candesartan cilexetil 8 and 16 mg vs. losartan 50 mg and found ... indicated true differences between the two drugs. It is interesting to note that the SBP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback